title: CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model.
abstract: Immunity to Leishmania is believed to be strongly dependent upon the activation of Th1 immune responses, although the exact role of cytotoxic T lymphocytes (CTLs) has not yet been determined. The aims of this study were to establish a suitable cytotoxicity assay to measure CTL activity and to compare immunity induced by Leishmania mexicana gp63 cDNA via i.m. injection and gene gun immunization in the BALB/c mouse model. The CTL activity was evaluated by short-term (51)Cr-release cytotoxicity assays against CT26 tumour cells transfected with L. mexicana gp63 cDNA and dendritic cells (DCs) loaded with soluble Leishmania antigen (SLA) as targets. The results clearly demonstrated that higher protection to L. mexicana infection was induced by gene gun DNA-immunization vs. i.m. injection. Cytotoxic T lymphocyte activity of splenocytes was observed in mice immunized either with L. mexicana gp63 cDNA or SLA and long-lived CTL activity was observed in immunized and/or re-challenged mice but not naïve mice infected with the parasite.
authors.affiliation: School of Science and Technology, Nottingham Trent University, Clifton, Nottingham, UK. selman.ali@ntu.ac.uk
authors.forename: S A
authors.initials: SA
authors.lastname: Ali
authors.forename: H
authors.initials: H
authors.lastname: Rezvan
authors.forename: S E
authors.initials: SE
authors.lastname: McArdle
authors.forename: A
authors.initials: A
authors.lastname: Khodadadi
authors.forename: F A
authors.initials: FA
authors.lastname: Asteal
authors.forename: R C
authors.initials: RC
authors.lastname: Rees
mesh_terms: D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D019470:Biolistics; D003601:Cytotoxicity Tests, Immunologic; D003602:Cytotoxicity, Immunologic; D018076:DNA, Complementary / Q000235:genetics; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D007074:Immunoglobulin G / Q000097:blood; D007273:Injections, Intramuscular; D007894:Leishmania mexicana / Q000235:genetics / Q000276:immunology*; D054332:Leishmaniasis Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D016773:Leishmaniasis, Cutaneous / Q000473:pathology / Q000517:prevention & control; D008666:Metalloendopeptidases / Q000235:genetics / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D012720:Severity of Illness Index; D013154:Spleen / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*
chemical_list: D000913:Antibodies, Protozoan; D018076:DNA, Complementary; D007074:Immunoglobulin G; D054332:Leishmaniasis Vaccines; D019444:Vaccines, DNA; D008666:Metalloendopeptidases; C055146:glycoprotein gp63, Leishmania